KIA
Kopp Investment Advisors Portfolio holdings
AUM
$54.4M
This Quarter Return
+12.79%
1 Year Return
+14.33%
3 Year Return
+109.21%
5 Year Return
+340.79%
10 Year Return
–
AUM
$221M
AUM Growth
+$221M
(-19%)
Cap. Flow
-$70.9M
Cap. Flow
% of AUM
-32.09%
Top 10 Holdings %
Top 10 Hldgs %
60.51%
Holding
90
New
3
Increased
14
Reduced
42
Closed
26
Top Buys
| 1 |
Extreme Networks
EXTR
|
$2.65M |
| 2 |
KFX
KOFAX LIMITED COM STK
KFX
|
$2.6M |
| 3 |
EMKR
Emcore Corp
EMKR
|
$1.67M |
| 4 |
OCLR
Oclaro Inc.
OCLR
|
$1.41M |
| 5 |
VTSS
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
|
$975K |
Top Sells
| 1 |
MSPD
MINDSPEED TECHNOLOGIES INC COM STK
MSPD
|
$6.82M |
| 2 |
AtriCure
ATRC
|
$5.94M |
| 3 |
Omnicell
OMCL
|
$5.51M |
| 4 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$4.22M |
| 5 |
SPNC
Spectranetics Corp
SPNC
|
$3.87M |
Sector Composition
| 1 | Technology | 46.62% |
| 2 | Healthcare | 22.58% |
| 3 | Consumer Staples | 4.04% |
| 4 | Financials | 1.92% |
| 5 | Industrials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Southern Company
SO
$102B
| $832K | 0.38% | 20,242 +2,185 | +12% | +$89.8K |
|
52
IBM
IBM
$227B
| $823K | 0.37% | 4,387 +348 | +9% | +$65.3K |
|
53
PepsiCo
PEP
$204B
| $794K | 0.36% | 9,576 -532 | -5% | -$44.1K |
|
54
Procter & Gamble
PG
$368B
| $765K | 0.35% | 9,396 -252 | -3% | -$20.5K |
|
55
NeoGenomics
NEO
$1.13B
| $550K | 0.25% | 152,057 -587,438 | -79% | -$2.12M |
|
56
Vanguard Total Stock Market ETF
VTI
$526B
| $374K | 0.17% | 3,900 | – | – |
|
57
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $239K | 0.11% | 3,000 | – | – |
|
58
Invesco QQQ Trust
QQQ
$364B
| $237K | 0.11% | 2,700 | – | – |
|
59
Ligand Pharmaceuticals
LGND
$3.15B
| $211K | 0.1% | 4,004 -39,135 | -91% | -$2.06M |
|
|
ACCL
60
DELISTED
ACCELRYS INC
ACCL
| $184K | 0.08% | 19,310 -206,016 | -91% | -$1.96M |
|
61
Cytokinetics
CYTK
$4.23B
| $176K | 0.08% | 27,001 -67,138 | -71% | -$438K |
|
|
PMCS
62
DELISTED
P M C SIERRA INC
PMCS
| $129K | 0.06% | 20,000 | – | – |
|
|
NXTM
63
DELISTED
NxStage Medical Inc.
NXTM
| $110K | 0.05% | +11,020 | New | +$110K |
|
64
LeMaitre Vascular
LMAT
$2.16B
| $107K | 0.05% | +13,415 | New | +$107K |
|
65
Align Technology
ALGN
$10.3B
| – | – | -19,472 | Closed | -$937K |
|
66
Alkermes
ALKS
$4.78B
| – | – | -36,604 | Closed | -$1.23M |
|
|
AMRN
67
Amarin Corp
AMRN
$311M
| – | – | -131,757 | Closed | -$833K |
|
68
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – | -11,691 | Closed | -$844K |
|
69
Celldex Therapeutics
CLDX
$1.47B
| – | – | -72,755 | Closed | -$2.58M |
|
70
HealthStream
HSTM
$832M
| – | – | -43,289 | Closed | -$1.64M |
|
71
Standard BioTools
LAB
$481M
| – | – | -42,036 | Closed | -$922K |
|
72
Masimo
MASI
$7.59B
| – | – | -31,870 | Closed | -$849K |
|
73
Vertex Pharmaceuticals
VRTX
$100B
| – | – | -9,380 | Closed | -$711K |
|
|
LCI
74
DELISTED
Lannett Company, Inc.
LCI
| – | – | -88,900 | Closed | -$1.94M |
|
|
GNMK
75
DELISTED
GenMark Diagnostics, Inc
GNMK
| – | – | -81,708 | Closed | -$992K |
|